[Bronchial asthma. Fluticasone propionate, a new inhalational corticosteroid defines new reference standards. "Advancing Corticosteroid Therapy" Symposium, Amsterdam, 6 May 1994].
D000280:Administration, Inhalation; D000328:Adult; D000730:Androstadienes / Q000008:administration & dosage* / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy*; D016535:Bronchial Hyperreactivity / Q000188:drug therapy; D002648:Child; D004305:Dose-Response Relationship, Drug; D000068298:Fluticasone; D006801:Humans
D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D000068298:Fluticasone
Asthma bronchiale. Fluticasonpropionat, ein neues inhalatives Kortikosteroid setzt neue Massstäbe. Symposium "Advancing Corticosteroid Therapy", Amsterdam, 6 Mai 1994.